Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Bruno

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Frontiers in Molecular Biosciences|August 28, 2020
Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical ImplicationsIrene Vanni, Enrica Teresa Tanda, Bruna Dalmasso, et al.
Dermatology Reports|September 4, 2025
Italian Melanoma Intergroup tele-genetic counseling project for melanoma predisposition syndromes: five-year evaluation of effectiveness and outcomesAndrea Carugno, Emanuela Passoni, Giovanna Pogliaghi, et al.
International Journal of Molecular Sciences|May 14, 2022
Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer PatientsBruna Dalmasso, Alberto Puccini, Fabio Catalano, et al.
Journal of the American Academy of Dermatology|October 3, 2018
CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patientsBruna Dalmasso, Lorenza Pastorino, Giulia Ciccarese, et al.
Journal of Genetic Counseling|November 3, 2020
Preferences of Italian patients for return of secondary findings from clinical genome/exome sequencingLea Godino, Liliana Varesco, William Bruno, et al.
Journal of Clinical Medicine|February 13, 2025
Age-Related Variations in Clinical, Histological, and Genetic Characteristics in Multiple and Familial Melanomas: A Study of 333 PatientsAndrea Carugno, Giovanni Paolino, Mario Valenti, et al.
Experimental Dermatology|July 19, 2012
MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patientsPaola Ghiorzo, Luigina Bonelli, Lorenza Pastorino, et al.
Oncotarget|February 22, 2018
Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variationsWilliam Bruno, Claudia Martinuzzi, Bruna Dalmasso, et al.
Human Mutation|June 29, 2004
Novel MC1R variants in Ligurian melanoma patients and controlsLorenza Pastorino, Roberto Cusano, William Bruno, et al.
Oncotarget|July 10, 2018
Correction: Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variationsWilliam Bruno, Claudia Martinuzzi, Bruna Dalmasso, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Frontiers in Molecular Biosciences|August 28, 2020
Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical ImplicationsIrene Vanni, Enrica Teresa Tanda, Bruna Dalmasso, et al.
Dermatology Reports|September 4, 2025
Italian Melanoma Intergroup tele-genetic counseling project for melanoma predisposition syndromes: five-year evaluation of effectiveness and outcomesAndrea Carugno, Emanuela Passoni, Giovanna Pogliaghi, et al.
International Journal of Molecular Sciences|May 14, 2022
Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer PatientsBruna Dalmasso, Alberto Puccini, Fabio Catalano, et al.
Journal of the American Academy of Dermatology|October 3, 2018
CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patientsBruna Dalmasso, Lorenza Pastorino, Giulia Ciccarese, et al.
Journal of Genetic Counseling|November 3, 2020
Preferences of Italian patients for return of secondary findings from clinical genome/exome sequencingLea Godino, Liliana Varesco, William Bruno, et al.
Journal of Clinical Medicine|February 13, 2025
Age-Related Variations in Clinical, Histological, and Genetic Characteristics in Multiple and Familial Melanomas: A Study of 333 PatientsAndrea Carugno, Giovanni Paolino, Mario Valenti, et al.
Experimental Dermatology|July 19, 2012
MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patientsPaola Ghiorzo, Luigina Bonelli, Lorenza Pastorino, et al.
Oncotarget|February 22, 2018
Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variationsWilliam Bruno, Claudia Martinuzzi, Bruna Dalmasso, et al.
Human Mutation|June 29, 2004
Novel MC1R variants in Ligurian melanoma patients and controlsLorenza Pastorino, Roberto Cusano, William Bruno, et al.
Oncotarget|July 10, 2018
Correction: Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variationsWilliam Bruno, Claudia Martinuzzi, Bruna Dalmasso, et al.
Pageof 7